Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy

20251 citationsJournal Article

Authors

Yvan Beaussant · Harvard University

Zachary Sager · Harvard University

Caitlin W. Brennan · Boston College

Isabel Kristan · Dana-Farber Cancer Institute

Michael Ljuslin · University Hospital of Geneva

Emanuele Mazzola · Dana-Farber Cancer Institute

David R. Macdonald ·

Abstract

This study provides initial evidence that PAT can be feasibly and safely integrated into hospice care for terminally ill patients. Further research is needed to optimise delivery and further assess therapeutic potential.

Topics & Keywords

Psychedelics and Drug Studies Cannabis and Cannabinoid Research Forensic Toxicology and Drug Analysis

Publication Details

Published in: BMJ Supportive & Palliative Care

Volume 16, Issue 2, pp. 423-433

DOI: 10.1136/spcare-2025-005773

Field-Weighted Citation Impact: 2.31

Command Palette

Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy

Authors

Abstract

Topics & Keywords

Publication Details